High Dose or High Dose Frequency Study of Alglucosidase Alfa

Clinical trial NCT00483379 · COMPLETED

Trial details

NCT number: NCT00483379
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pompe Disease Glycogen Storage Disease Type II (GSD-II)Glycogenesis 2 Acid Maltase Deficiency

Start date: 2007-05-01
Primary completion: 2009-12-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.